ProCE Banner Activity

Analysis of Healthcare Provider Treatment of Advanced Endometrial Cancer and Concordance With Expert Recommendations in 2023 vs 2022

PDF

This poster, presented at the 2024 ASCO Annual Meeting, illustrates discordance between healthcare professionals and experts in optimal selection of first-line and second-line treatment in case scenarios of patients with advanced endometrial cancer.

Released: June 03, 2024

Expiration: June 02, 2025

Share

Faculty

Hye Sook Chon

Hye Sook Chon, MD

Associate Professor
Clinical Trial Medical Director
Department of Gynecologic Oncology
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida

Linda R. Duska

Linda R. Duska, MD, MPH, FACOG, FACS, FASCO

Gynecologic Oncologist
Department of OB GYN/Gynecologic Oncology
University of Virginia School of Medicine
Charlottesville, Virginia

Ebony Hoskins

Ebony Hoskins, MD

Clinical Assistant Professor 
Obsterics and Gynecology; Gynecologic Oncology 
Georgetown University Medical Center 
Gynecologic Oncology 
WIS
Medstar Washington Hospital Center 
Washington, D.C.

Ritu Salani

Ritu Salani, MD, MBA

Professor and Division Director
Division of Gynecologic Oncology
Department of Obstetrics and Gynecology
University of California, Los Angeles
Los Angeles, California